DBV Technologies Management
Management criteria checks 3/4
DBV Technologies' CEO is Daniel Tassé, appointed in Nov 2018, has a tenure of 5.5 years. total yearly compensation is $2.40M, comprised of 25% salary and 75% bonuses, including company stock and options. directly owns 0.018% of the company’s shares, worth €20.58K. The average tenure of the management team and the board of directors is 4.8 years and 5.2 years respectively.
Key information
Daniel Tassé
Chief executive officer
US$2.4m
Total compensation
CEO salary percentage | 25.0% |
CEO tenure | 5.5yrs |
CEO ownership | 0.02% |
Management average tenure | 4.8yrs |
Board average tenure | 5.2yrs |
Recent management updates
Recent updates
Some DBV Technologies S.A. (EPA:DBV) Analysts Just Made A Major Cut To Next Year's Estimates
Mar 14DBV Technologies S.A. (EPA:DBV) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 10Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?
Dec 01Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?
Jun 23We're Hopeful That DBV Technologies (EPA:DBV) Will Use Its Cash Wisely
Mar 09Here's Why We're Not Too Worried About DBV Technologies' (EPA:DBV) Cash Burn Situation
Oct 04DBV Technologies S.A. (EPA:DBV) Shares Could Be 45% Below Their Intrinsic Value Estimate
Aug 06Here's Why DBV Technologies (EPA:DBV) Must Use Its Cash Wisely
Mar 14Will DBV Technologies (EPA:DBV) Spend Its Cash Wisely?
Oct 20We Think Some Shareholders May Hesitate To Increase DBV Technologies S.A.'s (EPA:DBV) CEO Compensation
May 12When Will DBV Technologies S.A. (EPA:DBV) Become Profitable?
May 06DBV Technologies S.A. (EPA:DBV) Analysts Just Trimmed Their Revenue Forecasts By 19%
Mar 31Could The DBV Technologies S.A. (EPA:DBV) Ownership Structure Tell Us Something Useful?
Mar 02CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$2m | US$600k | -US$73m |
Sep 30 2023 | n/a | n/a | -US$101m |
Jun 30 2023 | n/a | n/a | -US$101m |
Mar 31 2023 | n/a | n/a | -US$100m |
Dec 31 2022 | US$3m | US$600k | -US$96m |
Sep 30 2022 | n/a | n/a | -US$71m |
Jun 30 2022 | n/a | n/a | -US$77m |
Mar 31 2022 | n/a | n/a | -US$85m |
Dec 31 2021 | US$2m | US$600k | -US$98m |
Sep 30 2021 | n/a | n/a | -US$124m |
Jun 30 2021 | n/a | n/a | -US$131m |
Mar 31 2021 | n/a | n/a | -US$148m |
Dec 31 2020 | US$2m | US$600k | -US$160m |
Sep 30 2020 | n/a | n/a | -US$161m |
Jun 30 2020 | n/a | n/a | -US$171m |
Mar 31 2020 | n/a | n/a | -US$169m |
Dec 31 2019 | US$3m | US$600k | -US$172m |
Sep 30 2019 | n/a | n/a | -US$176m |
Jun 30 2019 | n/a | n/a | -US$198m |
Mar 31 2019 | n/a | n/a | -US$191m |
Dec 31 2018 | US$5m | US$55k | -US$190m |
Compensation vs Market: Daniel's total compensation ($USD2.40M) is above average for companies of similar size in the French market ($USD314.60K).
Compensation vs Earnings: Daniel's compensation has been consistent with company performance over the past year.
CEO
Daniel Tassé (63 yo)
5.5yrs
Tenure
US$2,404,486
Compensation
Mr. Daniel Tasse had been an Independent Non-Executive Director of Indivior PLC since August 2014 until May 6, 2021 and Senior Independent Director since September 30, 2016 until May 6, 2021. Mr. Tasse ser...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 5.5yrs | US$2.40m | 0.018% $ 20.6k | |
CFO & Principal Accounting Officer | less than a year | US$509.31k | no data | |
Chief Medical Officer | 4.8yrs | US$1.28m | 0.021% $ 23.7k | |
Chief Operations Officer | less than a year | no data | no data | |
Chief Legal Officer | 3.3yrs | no data | no data | |
Chief Human Resources Officer & Chief of Staff | 4.7yrs | no data | no data | |
Chief Clinical Trial Officer & Senior VP | 8yrs | no data | no data | |
Senior Vice President of Commercial Operations North America | 8.3yrs | no data | no data | |
Senior VP & Head of Global Regulatory Affairs | 5.3yrs | no data | no data | |
Chief External Manufacturing & Supply Chain Officer | less than a year | no data | no data |
4.8yrs
Average Tenure
55yo
Average Age
Experienced Management: DBV's management team is considered experienced (4.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 5.2yrs | US$2.40m | 0.018% $ 20.6k | |
Independent Director | 3.2yrs | US$113.54k | 0.012% $ 14.4k | |
Independent Chairman of the Board | 6yrs | US$10.81k | 0.025% $ 28.4k | |
Director | 8.6yrs | US$113.54k | 0% $ 0 | |
Independent Director | 9.2yrs | US$113.54k | 0.026% $ 30.1k | |
Director | 7.9yrs | no data | no data | |
Scientific Adviser to the CEO & Chairman of Scientific Advisory Board | 3.4yrs | no data | no data | |
Member of the Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 5yrs | no data | no data | |
Director | 6.9yrs | US$113.54k | 0% $ 0 | |
Member of Scientific Advisory Board | 5yrs | no data | no data | |
Member of Scientific Advisory Board | 5yrs | no data | no data |
5.2yrs
Average Tenure
63yo
Average Age
Experienced Board: DBV's board of directors are considered experienced (5.2 years average tenure).